Google Cloud’s Shweta Maniar is on a mission to revamp drug discovery with the power of generative AI, the trendy type of AI that can create new content. The tech is well-suited for a range of applications in drug discovery and across the life sciences. Whether it’s supporting organizations in their drug discovery efforts or…
Contrastive learning-based model ConPLEx elevates drug-protein interaction predictions
Drug discovery, traditionally a labor-intensive process, often involves extensive computational work during experimental screening. Advances in AI, however, promise to streamline this process. To that end, a team from MIT and Tufts has introduced ConPLex, a computational model that uses large language model techniques, similar to those behind ChatGPT. The model analyzes vast amounts of…